# Puma Biotechnology, Inc.: filings

PBYI · Nasdaq · CIK 1401667 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pbyi.md) · [Financials](/companies/pbyi/financials.md) · [Filings](/companies/pbyi/filings.md) · [Insiders](/companies/pbyi/insiders.md)

## Reports and events: 311 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 437, 8-K 205, 144 67, SC 13G/A 67, 10-Q 53, SC 13G 30, DEFA14A 24, 3 23, 10-K 18, UPLOAD 18, DEF 14A 15, CORRESP 14, 424B3 10, 4/A 8, CT ORDER 8, S-8 8, SC 13D/A 8, ARS 7, DFAN14A 7, EFFECT 7, SCHEDULE 13G/A 6, 424B1 4, 424B5 4, S-1/A 4, 8-K/A 3, PRE 14A 3, PRER14A 3, S-3 3, 8-A12B 2, D 2, DEFC14A 2, DEFR14A 2, POS AM 2, PREC14A 2, PRRN14A 2, S-1 2, 10-Q/A 1, 144/A 1, 25 1, 424B2 1, CERTNAS 1, CERTNYS 1, D/A 1, DEF 14C 1, FWP 1, NT 10-K 1, PRE 14C 1, S-1MEF 1, S-3/A 1, S-3ASR 1, S-3MEF 1, SC 13D 1, SC 14F1 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 01:37 ET | [SCHEDULE 13D/A](/filings/0001104659-26-114167.md) | Ownership report, active investor, amended | 0001104659-26-114167 |
| 2026-08-06 | 20:41 ET | [10-Q](/filings/0001437749-26-026311.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026311 |
| 2026-08-06 | 20:19 ET | [8-K](/filings/0001437749-26-026282.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026282 |
| 2026-06-16 | 20:06 ET | [8-K](/filings/0001437749-26-020793.md) | 5.07 Shareholder vote results | 0001437749-26-020793 |
| 2026-05-07 | 20:41 ET | [10-Q](/filings/0001437749-26-015633.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015633 |
| 2026-05-07 | 20:32 ET | [8-K](/filings/0001437749-26-015621.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015621 |
| 2026-04-28 | 20:15 ET | [DEF 14A](/filings/0001437749-26-013671.md) | Proxy statement, period 2026-06-11 | 0001437749-26-013671 |
| 2026-02-26 | 21:41 ET | [10-K](/filings/0001437749-26-005891.md) | Annual report, period 2025-12-31 | 0001437749-26-005891 |
| 2026-02-26 | 21:16 ET | [8-K](/filings/0001437749-26-005869.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-005869 |
| 2025-11-06 | 21:41 ET | [10-Q](/filings/0001437749-25-033633.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033633 |
| 2025-11-06 | 21:16 ET | [8-K](/filings/0001437749-25-033604.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033604 |
| 2025-08-07 | 20:41 ET | [10-Q](/filings/0001437749-25-025470.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025470 |
| 2025-08-07 | 20:32 ET | [8-K](/filings/0001437749-25-025463.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025463 |
| 2025-08-07 | 01:35 ET | [10-Q/A](/filings/0001437749-25-025214.md) | Quarterly report, amended, period 2025-03-31 | 0001437749-25-025214 |
| 2025-06-24 | 20:06 ET | [8-K](/filings/0001437749-25-021153.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-25-021153 |
| 2025-06-13 | 20:07 ET | [8-K](/filings/0001437749-25-020321.md) | 5.07 Shareholder vote results | 0001437749-25-020321 |
| 2025-05-09 | 12:57 ET | [8-K](/filings/0001437749-25-015648.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-015648 |
| 2025-05-08 | 20:41 ET | [10-Q](/filings/0001437749-25-015533.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015533 |
| 2025-05-08 | 20:20 ET | [8-K](/filings/0001437749-25-015514.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015514 |
| 2025-04-28 | 20:18 ET | [DEF 14A](/filings/0001437749-25-013337.md) | Proxy statement, period 2025-06-11 | 0001437749-25-013337 |
| 2025-02-27 | 21:41 ET | [10-K](/filings/0001437749-25-005496.md) | Annual report, period 2024-12-31 | 0001437749-25-005496 |
| 2025-02-27 | 21:22 ET | [8-K](/filings/0001437749-25-005477.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005477 |
| 2024-11-07 | 21:40 ET | [10-Q](/filings/0001437749-24-033955.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033955 |
| 2024-11-07 | 21:14 ET | [8-K](/filings/0001437749-24-033929.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-033929 |
| 2024-09-16 | 13:01 ET | [8-K](/filings/0001437749-24-029206.md) | 8.01 Other events | 0001437749-24-029206 |
| 2024-08-15 | 13:00 ET | [8-K](/filings/0001437749-24-026953.md) | 8.01 Other events | 0001437749-24-026953 |
| 2024-08-07 | 13:00 ET | [8-K](/filings/0001437749-24-025027.md) | 8.01 Other events | 0001437749-24-025027 |
| 2024-08-01 | 20:41 ET | [10-Q](/filings/0001437749-24-024309.md) | Quarterly report, period 2024-06-30 | 0001437749-24-024309 |
| 2024-08-01 | 20:17 ET | [8-K](/filings/0001437749-24-024297.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-024297 |
| 2024-06-24 | 20:18 ET | [8-K](/filings/0001437749-24-021086.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-021086 |
| 2024-05-17 | 20:43 ET | [8-K](/filings/0001437749-24-017504.md) | 8.01 Other events | 0001437749-24-017504 |
| 2024-05-02 | 20:41 ET | [10-Q](/filings/0001437749-24-014395.md) | Quarterly report, period 2024-03-31 | 0001437749-24-014395 |
| 2024-05-02 | 20:18 ET | [8-K](/filings/0001437749-24-014382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014382 |
| 2024-04-26 | 12:10 ET | [DEF 14A](/filings/0001437749-24-013309.md) | Proxy statement, period 2024-06-18 | 0001437749-24-013309 |
| 2024-03-19 | 20:05 ET | [8-K](/filings/0001437749-24-008508.md) | 8.01 Other events | 0001437749-24-008508 |
| 2024-02-29 | 21:41 ET | [10-K](/filings/0001437749-24-006121.md) | Annual report, period 2023-12-31 | 0001437749-24-006121 |
| 2024-02-29 | 21:16 ET | [8-K](/filings/0001437749-24-006099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-006099 |
| 2024-01-18 | 14:00 ET | [8-K](/filings/0001437749-24-001581.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001581 |
| 2023-11-02 | 20:40 ET | [10-Q](/filings/0001437749-23-030028.md) | Quarterly report, period 2023-09-30 | 0001437749-23-030028 |
| 2023-11-02 | 20:19 ET | [8-K](/filings/0001437749-23-030014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-030014 |
| 2023-09-26 | 20:10 ET | [8-K](/filings/0001437749-23-026766.md) | 7.01 Regulation FD disclosure | 0001437749-23-026766 |
| 2023-08-18 | 20:17 ET | [8-K](/filings/0001437749-23-024168.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-024168 |
| 2023-08-03 | 20:41 ET | [10-Q](/filings/0001437749-23-021972.md) | Quarterly report, period 2023-06-30 | 0001437749-23-021972 |
| 2023-08-03 | 20:12 ET | [8-K](/filings/0001437749-23-021937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021937 |
| 2023-06-15 | 21:10 ET | [8-K](/filings/0001437749-23-017581.md) | 5.07 Shareholder vote results | 0001437749-23-017581 |
| 2023-05-04 | 20:41 ET | [10-Q](/filings/0001437749-23-012589.md) | Quarterly report, period 2023-03-31 | 0001437749-23-012589 |
| 2023-05-04 | 20:16 ET | [8-K](/filings/0001437749-23-012576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-012576 |
| 2023-04-28 | 12:10 ET | [DEF 14A](/filings/0001437749-23-011500.md) | Proxy statement | 0001437749-23-011500 |
| 2023-03-02 | 21:41 ET | [10-K](/filings/0001437749-23-005233.md) | Annual report, period 2022-12-31 | 0001437749-23-005233 |
| 2023-03-02 | 21:11 ET | [8-K](/filings/0001437749-23-005220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-005220 |

Page 1 of 7. [Older](/companies/pbyi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.